{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:59:28Z","timestamp":1791280768789,"version":"4.1.0"},"reference-count":26,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,6,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In this study we quantified the proliferation rate of normal and malignant plasma cells (PCs) by ex vivo incorporation of 5-bromo-2\u2032-deoxyuridine (BrdU; labeling index, LI) using flow cytometry. We show that all bone marrow PCs, either normal or malignant, include a subset of proliferating PCs present within the CD45bright fraction. Indeed, medullary normal and malignant PCs were always heterogeneous for CD45 expression, and proliferation was always restricted primarily to the CD45bright compartment. Moreover, an inverse correlation was found between LI or CD45 and B-cell lymphoma 2 (Bcl-2) in both malignant and normal PCs, the most proliferating CD45bright PCs have the lowest Bcl-2 expression. We investigated expression of molecules of interest in multiple myeloma (MM)\u2014that is, CD138, CD19, CD20, CD27, CD28, CD56, and CD11a\u2014to further characterize the CD45bright fraction. Among all of these molecules, only CD11a was exclusively expressed by CD45bright proliferating myeloma cells. In conclusion, proliferating myeloma cells are characterized by the specific CD45bright CD11apos Bcl-2low phenotype. (Blood. 2005;105:4845-4848)<\/jats:p>","DOI":"10.1182\/blood-2004-12-4700","type":"journal-article","created":{"date-parts":[[2005,3,2]],"date-time":"2005-03-02T03:38:02Z","timestamp":1109734682000},"page":"4845-4848","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":55,"title":["Phenotypic characterization of the human myeloma cell growth fraction"],"prefix":"10.1182","volume":"105","author":[{"given":"Nelly","family":"Robillard","sequence":"first","affiliation":[{"name":"From the Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (INSERM) UMR601, De\u0301partement de Recherche en Cance\u0301rologie, Nantes, France; and the Central Laboratory of Hematology University Hospital, Nantes, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Pellat-Deceunynck","sequence":"additional","affiliation":[{"name":"From the Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (INSERM) UMR601, De\u0301partement de Recherche en Cance\u0301rologie, Nantes, France; and the Central Laboratory of Hematology University Hospital, Nantes, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Re\u0301gis","family":"Bataille","sequence":"additional","affiliation":[{"name":"From the Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (INSERM) UMR601, De\u0301partement de Recherche en Cance\u0301rologie, Nantes, France; and the Central Laboratory of Hematology University Hospital, Nantes, France."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021223364444800_REF1","doi-asserted-by":"crossref","unstructured":"Drewinko B, Alexanian R, Boyer H, Barlogie B, Rubinow SI. The growth fraction of human myeloma cells. Blood.1981;57: 333-338.","DOI":"10.1182\/blood.V57.2.333.333"},{"key":"2020021223364444800_REF2","unstructured":"Jackson N, Ling NR, Ball JJ, Bromidge E, Nathan PD, Franklin IM. An analysis of myeloma plasma cell phenotype using antibodies defined at the IIIrd international workshop on human leukocyte differentiation antigens. Clin Exp Immunol.1988;72: 351-356."},{"key":"2020021223364444800_REF3","unstructured":"Pellat-Deceunynck C, Barille\u0301 S, Puthier D, et al. Adhesion molecules on human myeloma cells: significant changes in expression related to malignancy, tumor spreading, and immortalization. Cancer Res.1995;55: 3647-3653."},{"key":"2020021223364444800_REF4","doi-asserted-by":"crossref","unstructured":"Pope B, Brown R, Gibson J, Joshua D. The bone marrow plasma cell labeling index by flow cytometry. Cytometry.1999;38: 286-292.","DOI":"10.1002\/(SICI)1097-0320(19991215)38:6<286::AID-CYTO5>3.0.CO;2-7"},{"key":"2020021223364444800_REF5","doi-asserted-by":"crossref","unstructured":"Fujii R, Ishikawa H, Mahmoud MS, Asaoku H, Kawano MM. MPC-1-CD49e- immature myeloma cells include CD45+ subpopulations that can proliferate in response to IL-6 in human myelomas. Br J Haematol.1999;105: 131-140.","DOI":"10.1111\/j.1365-2141.1999.01281.x"},{"key":"2020021223364444800_REF6","doi-asserted-by":"crossref","unstructured":"Medina F, Segundo C, Campos-Caro A, Gonzalez-Garcia I, Brieva JA. The heterogeneity shown by human plasma cells from tonsil, blood, and bone marrow reveals graded stages of increasing maturity, but local profiles of adhesion molecule expression. Blood.2002;99: 2154-2161.","DOI":"10.1182\/blood.V99.6.2154"},{"key":"2020021223364444800_REF7","doi-asserted-by":"crossref","unstructured":"Terstappen LW, Johnsen S, Segers-Nolten IM, Loken MR. Identification and characterization of plasma cells in normal human bone marrow by high-resolution flow cytometry. Blood.1990;76: 1739-1747.","DOI":"10.1182\/blood.V76.9.1739.1739"},{"key":"2020021223364444800_REF8","doi-asserted-by":"crossref","unstructured":"Harada Y, Kawano M, Huang N, et al. Identification of early plasma cells in peripheral blood and their clinical significance. Br J Haematol.1996;92: 184-191.","DOI":"10.1046\/j.1365-2141.1996.300835.x"},{"key":"2020021223364444800_REF9","unstructured":"Ocqueteau M, Orfao A, Almeida J, et al. Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Am J Pathol.1998;152: 1655-1665."},{"key":"2020021223364444800_REF10","doi-asserted-by":"crossref","unstructured":"Jelinek DF, Lipsky PE. The role of B cell proliferation in the generation of immunoglobulin-secreting cells in man. J Immunol.1983;130: 2597-2604.","DOI":"10.4049\/jimmunol.130.6.2597"},{"key":"2020021223364444800_REF11","doi-asserted-by":"crossref","unstructured":"Arpin C, Banchereau J, Liu YJ. Memory B cells are biased towards terminal differentiation: a strategy that may prevent repertoire freezing. J Exp Med.1997;186: 931-940.","DOI":"10.1084\/jem.186.6.931"},{"key":"2020021223364444800_REF12","doi-asserted-by":"crossref","unstructured":"Jego G, Robillard N, Puthier D, et al. Reactive plasmacytoses are expansions of plasmablasts retaining the capacity to differentiate into plasma cells. Blood.1999;94: 701-712.","DOI":"10.1182\/blood.V94.2.701"},{"key":"2020021223364444800_REF13","doi-asserted-by":"crossref","unstructured":"Jego G, Bataille R, Pellat-Deceunynck C. Interleukin-6 is a growth factor for nonmalignant human plasmablasts. Blood.2001;97: 1817-1822.","DOI":"10.1182\/blood.V97.6.1817"},{"key":"2020021223364444800_REF14","doi-asserted-by":"crossref","unstructured":"Robillard N, Avet-Loiseau H, Garand R, et al. CD20 is associated with a small mature plasma cell morphology and t(11;14) in multiple myeloma. Blood.2003;102: 1070-1071.","DOI":"10.1182\/blood-2002-11-3333"},{"key":"2020021223364444800_REF15","doi-asserted-by":"crossref","unstructured":"Zhang C, Ao Z, Seth A, Schlossman SF. A mitochondrial membrane protein defined by a novel monoclonal antibody is preferentially detected in apoptotic cells. J Immunol.1996;157: 3980-3987.","DOI":"10.4049\/jimmunol.157.9.3980"},{"key":"2020021223364444800_REF16","doi-asserted-by":"crossref","unstructured":"Puthier D, Pellat-Deceunynck C, Barille\u0301 S, et al. Differential expression of Bcl-2 in human plasma cell disorders according to proliferation status and malignancy. Leukemia.1999;13: 289-294.","DOI":"10.1038\/sj.leu.2401302"},{"key":"2020021223364444800_REF17","doi-asserted-by":"crossref","unstructured":"Huang D, O'Reilly L, Strasser A, Cory S. The anti-apoptosis function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry. EMBO J.1997;16: 4628-4638.","DOI":"10.1093\/emboj\/16.15.4628"},{"key":"2020021223364444800_REF18","doi-asserted-by":"crossref","unstructured":"Strasser A, Whittingham S, Vaux DL, et al. Enforced Bcl-2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc Natl Acad Sci U S A.1991;88: 8661-8665.","DOI":"10.1073\/pnas.88.19.8661"},{"key":"2020021223364444800_REF19","doi-asserted-by":"crossref","unstructured":"Ahsmann EJM, Lokhorst HM, Dekker AW, Bloem AC. Lymphocyte function-associated antigen-1 expression on plasma cells correlates with tumor growth in multiple myeloma. Blood.1992;79: 2068-2075.","DOI":"10.1182\/blood.V79.8.2068.2068"},{"key":"2020021223364444800_REF20","unstructured":"Pellat-Deceunynck C, Amiot M, Robillard N, Wijdenes J, Bataille R. CD11a-CD18 and CD102 interactions mediate myeloma cell growth arrest induced by CD40 stimulation. Cancer Res.1996;56: 1909-1916."},{"key":"2020021223364444800_REF21","doi-asserted-by":"crossref","unstructured":"Kawano M, Hirano T, Matsuda T, et al. Autocrine generation and requirement of BSF-2\/IL-6 for human multiple myelomas. Nature.1998;332: 83-85.","DOI":"10.1038\/332083a0"},{"key":"2020021223364444800_REF22","doi-asserted-by":"crossref","unstructured":"Klein B, Zhang X-G, Jourdan M, et al. Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by Interleukin-6. Blood.1989;73: 517-526.","DOI":"10.1182\/blood.V73.2.517.517"},{"key":"2020021223364444800_REF23","doi-asserted-by":"crossref","unstructured":"Mahmoud MS, Ishikawa H, Fujii R, Kawano M. Induction of CD45 expression and proliferation in U-266 myeloma cell line by interleukin-6. Blood.1988;92: 3887-3897.","DOI":"10.1182\/blood.V92.10.3887"},{"key":"2020021223364444800_REF24","doi-asserted-by":"crossref","unstructured":"Ishikawa H, Tsuyama N, Abroun S, et al. Requirements of src family kinase activity associated with CD45 for myeloma cells proliferation by interleukin-6. Blood.2002;99: 2172-2176.","DOI":"10.1182\/blood.V99.6.2172"},{"key":"2020021223364444800_REF25","doi-asserted-by":"crossref","unstructured":"Hata H, Xiao H, Petrucci MT, Woodliff J, Chang R, Epstein J. Interleukin-6 gene expression in multiple myeloma: a characteristic of immature tumor cells. Blood.1993;81: 3357-3364.","DOI":"10.1182\/blood.V81.12.3357.3357"},{"key":"2020021223364444800_REF26","doi-asserted-by":"crossref","unstructured":"Kawano MM, Mihara K, Huang N, Tsujimoto T, Kuramoto A. Differentiation of early plasma cells on bone marrow stromal cells requires interleukin-6 for escaping from apoptosis. Blood.1995;85: 487-494.","DOI":"10.1182\/blood.V85.2.487.487"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/105\/12\/4845\/1711074\/zh801205004845.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/105\/12\/4845\/1711074\/zh801205004845.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T14:43:18Z","timestamp":1683038598000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/105\/12\/4845\/19755\/Phenotypic-characterization-of-the-human-myeloma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6,15]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005,6,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2004-12-4700","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,6,15]]}}}